Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
12112studies shown
Showing 7,573-7,584 of 12,112
Behavioral study icon
CompletedNCT03685279

Efficacy of the Nurtured Heart Approach to Reduce ADHD Behaviors in Children

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Tucson
ADHDOtherOver 18 Years
Countries
United States
Sponsor
University of Arizona
Condition
ADHD
Device study icon
CompletedNCT05374187

Efficacy of Trigeminal Nerve Stimulation for ADHD

This observational study is following people with Attention-Deficit Hyperactivity Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Los Angeles
ADHDOtherFrom 7 Years to 12 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
ADHD
Other study type icon
CompletedNCT05130853

Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in people with Schizophrenia

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Naples
SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Italy
Sponsor
University of Campania Luigi Vanvitelli
Condition
Schizophrenia
Drug study icon
CompletedNCT03653858

Efficacy Study of Deep Brain Stimulation in people with Treatment Resistant Major Depression

This study exists to compare options and see whether the medication Deep offers something meaningfully different. Researchers are trying to understand what the medication Deep can reveal about signals in the brain or body that may guide care later on.

Multiple locations, including Grenoble
DepressionOtherFrom 20 Years to 75 Years
Countries
France, Germany
Sponsor
University Hospital Freiburg
Condition
Depression
Drug study icon
TerminatedNCT01093963

Efficacy Study of Lisdexamfetamine to Treat Depression in bipolarity

This study exists to understand whether the medication Lisdexamfetamine is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In Mason
Bipolarity, DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT01340690

Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder

This study exists to compare options and see whether the medication Polyunsaturated offers something meaningfully different. Researchers are trying to understand whether the medication Polyunsaturated can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Bad Neuenahr
ADHDOtherFrom 6 Years to 17 Years
Countries
Germany
Sponsor
Johannes Gutenberg University Mainz
Condition
ADHD
Drug study icon
CompletedNCT03115671

Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Vayarin offers something meaningfully different. Researchers are trying to understand whether the medication Vayarin can improve attention, thinking, or day-to-day functioning.

In Singapore
ADHDOtherFrom 6 Years to 12 Years
Countries
Singapore
Sponsor
Institute of Mental Health, Singapore
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.